Home Life Sciences Interplay between reversible phosphorylation and irreversible ADP-ribosylation of eukaryotic translation elongation factor 2
Article
Licensed
Unlicensed Requires Authentication

Interplay between reversible phosphorylation and irreversible ADP-ribosylation of eukaryotic translation elongation factor 2

  • , , , , , , , , and EMAIL logo
Published/Copyright: September 15, 2018

Abstract

The functionality of eukaryotic translation elongation factor 2 (eEF2) is modulated by phosphorylation, eEF2 is simultaneously the molecular target of ADP-ribosylating toxins. We analyzed the interplay between phosphorylation and diphthamide-dependent ADP-ribosylation. Phosphorylation does not require diphthamide, eEF2 without it still becomes phosphorylated. ADP-ribosylation not only modifies the H715 diphthamide but also inhibits phosphorylation of S595 located in proximity to H715, and stimulates phosphorylation of T56. S595 can be phosphorylated by CDK2 and CDK1 which affects EEF2K-mediated T56-phosphorylation. Thus, ADP-ribosylation and S595-phosphorylation by kinases occur within the same vicinity and both trigger T56-phosphorylation. Diphthamide is surface-accessible permitting access to ADP-ribosylating enzymes, the adjacent S595 side chain extends into the interior. This orientation is incompatible with phosphorylation, neither allowing kinase access nor phosphate attachment. S595 phosphorylation must therefore be accompanied by structural alterations affecting the interface to ADP-ribosylating toxins. In agreement with that, replacement of S595 with Ala, Glu or Asp prevents ADP-ribosylation. Phosphorylation (starvation) as well as ADP-ribosylation (toxins) inhibit protein synthesis, both affect the S595/H715 region of eEF2, both trigger T57-phosphorylation eliciting similar transcriptional responses. Phosphorylation is short lived while ADP-ribosylation is stable. Thus, phosphorylation of the S595/H715 ‘modifier region’ triggers transient interruption of translation while ADP-ribosylation arrests irreversibly.

Acknowledgments

This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.

  1. Conflict of interest statement:

  2. R.M.-S., S.S., S.D., F.B., H.H., K.M., G.N. and U.B. are employed by Roche Pharma Research & Early Development. Roche is interested in identifying novel targets and approaches for disease diagnosis and therapy.

References

Balasubramanian, M., Shan, J., and Kilberg, M. (2013). Dynamic changes in genomic histone association and modification during activation of the ASNS and ATF3 genes by amino acid limitation. Biochem. J. 449, 219.10.1042/BJ20120958Search in Google Scholar

Chen, Z., Gopalakrishnan, S.M., Bui, M.H., Soni, N.B., Warrior, U., Johnson, E.F., Donnelly, J.B., and Glaser, K.B. (2011). 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. J. Biol. Chem. 286, 43951–43958.10.1074/jbc.M111.301291Search in Google Scholar

Dong, M., Su, X., Dzikovski, B., Dando, E.E., Zhu, X., Du, J., Freed, J.H., and Lin, H. (2014). Dph3 Is an electron donor for Dph1-Dph2 in the first step of eukaryotic diphthamide biosynthesis. J. Am. Chem. Soc. 136, 1754–1757.10.1021/ja4118957Search in Google Scholar

Hassan, R., Alewine, C., and Pastan, I. (2016). New life for immunotoxin cancer therapy. Clin. Cancer Res. 22, 1055.10.1158/1078-0432.CCR-15-1623Search in Google Scholar

Hizli, A.A., Chi, Y., Swanger, J., Carter, J.H., Liao, Y., Welcker, M., Ryazanov, A.G., and Clurman, B.E. (2013). Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase. Mol. Cell. Biol. 33, 596.10.1128/MCB.01270-12Search in Google Scholar

Horman, S., Browne, G.J., Krause, U., Patel, J.V., Vertommen, D., Bertrand, L., Lavoinne, A., Hue, L., Proud, C.G., and Rider, M.H. (2002). Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12, 1419–1423.10.1016/S0960-9822(02)01077-1Search in Google Scholar

Hu, X., Wei, H., Xiang, L., Chertov, O., Wayne, A.S., Bera, T.K., and Pastan, I. (2013). Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8. Leukemia Res. 37, 1551–1556.10.1016/j.leukres.2013.08.005Search in Google Scholar PubMed PubMed Central

Joergensen, R., Wang, Y., Visschedyk, D., and Merrill, A.R. (2008). The nature and character of the transition state for the ADP-ribosyltransferase reaction. EMBO Rep. 9, 802–809.10.1038/embor.2008.90Search in Google Scholar PubMed PubMed Central

Kaul, G., Pattan, G., and Rafeequi, T. (2011). Eukaryotic elongation factor-2 (eEF2): its regulation and peptide chain elongation. Cell Biochem. Funct. 29, 227–234.10.1002/cbf.1740Search in Google Scholar PubMed

Kilberg, M.S., Balasubramanian, M., Fu, L., and Shan, J. (2012). The transcription factor network associated with the amino acid response in mammalian cells. Adv. Nutr. 3, 295–306.10.3945/an.112.001891Search in Google Scholar PubMed PubMed Central

Leprivier, G., Remke, M., Rotblat, B., Dubuc, A., Mateo, A.R., Kool, M., Agnihotri, S., El-Naggar, A., Yu, B., Prakash-áSomasekharan, S., et al. (2013). The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 153, 1064–1079.10.1016/j.cell.2013.04.055Search in Google Scholar

Liu, S., Bachran, C., Gupta, P., Miller-Randolph, S., Wang, H., Crown, D., Zhang, Y., Wein, A.N., Singh, R., Fattah, R., et al. (2012). Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development. Proc. Natl. Acad. Sci. USA 109, 13817.10.1073/pnas.1206933109Search in Google Scholar

Mattheakis, L.C., Shen, W.H., and Collier, R.J. (1992). DPH5, a methyltransferase gene required for diphthamide biosynthesis in Saccharomyces cerevisiae. Mol. Cell. Biol. 12, 4026.10.1128/MCB.12.9.4026Search in Google Scholar

Mayer, K., Schroeder, A., Schnitger, J., Stahl, S., and Brinkmann, U. (2017). Influence of DPH1 and DPH5 protein variants on the synthesis of diphthamide, the target of ADPRibosylating toxins. Toxins 9, 78.10.3390/toxins9030078Search in Google Scholar

Merrick, W.C. (1992). Mechanism and regulation of eukaryotic protein synthesis. Microbiol. Rev. 56, 291–315.10.1128/mr.56.2.291-315.1992Search in Google Scholar

Nobukuni, Y., Kohno, K., and Miyagawa, K. (2005). Gene trap mutagenesis-based forward genetic approach reveals that the tumor suppressor OVCA1 is a component of the biosynthetic pathway of diphthamide on elongation factor 2. J. Biol. Chem. 280, 10572–10577.10.1074/jbc.M413017200Search in Google Scholar

Ovchinnikov, L.P., Motuz, L.P., Natapov, P.G., Averbuch, L.J., Wettenhall, R.E.H., Szyszka, R., Kramer, G., and Hardesty, B. (1990). Three phosphorylation sites in elongation factor 2. FEBS Lett. 275, 209–212.10.1016/0014-5793(90)81473-2Search in Google Scholar

Pasetto, M., Antignani, A., Ormanoglu, P., Buehler, E., Guha, R., Pastan, I., Martin, S.E., and FitzGerald, D.J. (2015). Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 112, E1135.10.1073/pnas.1501958112Search in Google Scholar

Pastan, I., Hassan, R., FitzGerald, D.J., and Kreitman, R.J. (2006). Immunotoxin therapy of cancer. Nat. Rev. Cancer 6, 559.10.1038/nrc1891Search in Google Scholar

Price, N.T., Redpath, N.T., Severinov, K.V., Campbell, D.G., Russell, J.M., and Proud, C.G. (1991). Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes. FEBS Lett. 282, 253–258.10.1016/0014-5793(91)80489-PSearch in Google Scholar

Schaffrath, R., bdel-Fattah, W., Klassen, R., and Stark, M.J.R. (2014). The diphthamide modification pathway from Saccharomyces cerevisiae revisited. Mol. Microbiol. 94, 1213–1226.10.1111/mmi.12845Search in Google Scholar PubMed

Shan, J., Lopez, M.C., Baker, H.V., and Kilberg, M.S. (2010). Expression profiling after activation of amino acid deprivation response in HepG2 human hepatoma cells. Physiol. Genomics 41, 315–327.10.1152/physiolgenomics.00217.2009Search in Google Scholar

Stahl, S., Mueller, F., Pastan, I., and Brinkmann, U. (2015a). Factors that determine sensitivity and resistances of tumor cells towards antibody-targeted protein toxins. In: Resistance to Immunotoxins in Cancer Therapy. Resistance to Targeted Anti-Cancer Therapeutics, R. Verma and B. Bonavida, eds. (Cham, Switzerland: Springer).10.1007/978-3-319-17275-0_3Search in Google Scholar

Stahl, S., da Silva Mateus Seidl, A.R., Ducret, A., Kux van Geijtenbeek, S., Michel, S., Racek, T., Birzele, F., Haas, A.K., Rueger, R., Gerg, M., et al. (2015b). Loss of diphthamide pre-activates NFkB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor. Proc. Natl. Acad. Sci. USA 112, 10732.10.1073/pnas.1512863112Search in Google Scholar

Su, X., Lin, Z., and Lin, H. (2013). The biosynthesis and biological function of diphthamide. Crit. Rev. Biochem. Mol. Biol. 48, 515–521.10.3109/10409238.2013.831023Search in Google Scholar

Van Ness, B.G., Howard, J.B., and Bodley, J.W. (1980). ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. J. Biol. Chem. 255, 10717–10720.10.1016/S0021-9258(19)70366-4Search in Google Scholar

Webb, T.R., Cross, S.H., McKie, L., Edgar, R., Vizor, L., Harrison, J., Peters, J., and Jackson, I.J. (2008). Diphthamide modification of eEF2 requires a J-domain protein and is essential for normal development. J. Cell Sci. 121, 3140.10.1242/jcs.035550Search in Google Scholar PubMed PubMed Central

Wei, H., Xiang, L., Wayne, A.S., Chertov, O., FitzGerald, D.J., Bera, T.K., and Pastan, I. (2012). Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy. Proc. Natl. Acad. Sci. USA 109, 6898.10.1073/pnas.1204523109Search in Google Scholar PubMed PubMed Central

Wei, H., Bera, T.K., Wayne, A.S., Xiang, L., Colantonio, S., Chertov, O., and Pastan, I. (2013). A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene. J. Biol. Chem. 288, 12305–12312.10.1074/jbc.M113.461343Search in Google Scholar PubMed PubMed Central

Zhang, Y., Liu, S., Lajoie, G., and Merrill, A. (2008). The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A. Biochem. J. 413, 163.10.1042/BJ20071083Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/hsz-2018-0280).


Received: 2018-06-07
Accepted: 2018-09-11
Published Online: 2018-09-15
Published in Print: 2019-04-24

©2019 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 23.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/hsz-2018-0280/html
Scroll to top button